Correction: Clinical feasibility of gastric endoscopic submucosal dissection in patients on glucocorticoids or immunomodulators: Propensity-score-matched study
Pain n = 24 (9 GC/IM vs 15 standard) Analgetics n = 8 (33.3 %, 5 vs 3) Antipyretics n = 0 (0 %) Antibiotics n = 2 (8.3 %, 1 vs 1)Analgetics n = 2 (50 %, 2 vs 0) Antipyretics n = 2 (50 %, 2 vs 0) Antibiotics n = 1 (25 %, 1 vs 1)Analgetics n = 0 (0 %) Antipyretics n = 0 (0 %) Antibiotics n = 2 (2.5 %, 0 vs 2) C10
Authors
- Yorinobu Sumida (ORCID: https://orcid.org/0000-0002-7709-6421)
- Akihisa Ohno (ORCID: https://orcid.org/0000-0003-1372-166X)
- Taisuke Sasaki (ORCID: https://orcid.org/0000-0002-5952-7638)
- Hitoshi Homma
- Hiroki Fukuya (ORCID: https://orcid.org/0000-0001-9570-9319)
- Ryota Okitsu
- Naohiko Harada (ORCID: https://orcid.org/0000-0002-8412-1031)
- Shuichi Itonaga
- Eikichi Ihara
- Yoichiro Iboshi
- Akito Ohkubo
- Daisuke Yoshimura
- Mitsuru Esaki
- Shohei Hamada
Institutions
- Kyushu University (JP)
- National Kyushu Medical Center (JP)
- Kitakyushu Municipal Medical Center (JP)
Publication Details
- Journal
- Endoscopy International Open
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1055/a-2823-6852
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00